In Regard to A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08)

This letter to the editor remarks on a recently published article on the use of NUC-1031 and cisplatin for patients with biliary tract cancer and compares results of the landmark ABC-02 trial.

Automated summary

This letter to the editor discusses a recent article on the use of NUC-1031 and cisplatin in patients with biliary tract cancer, comparing the results to the landmark ABC-02 trial.